Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
3(21%)
Results Posted
50%(4 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
1
7%
Ph early_phase_1
1
7%
Ph not_applicable
12
86%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 1Safety & dosage
1(7.1%)
N/ANon-phased studies
12(85.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(5)
Completed(8)
Terminated(1)

Detailed Status

Completed8
Recruiting3
Not yet recruiting1
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
88.9%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (7.1%)
Phase 11 (7.1%)
N/A12 (85.7%)

Trials by Status

not_yet_recruiting17%
recruiting321%
enrolling_by_invitation17%
terminated17%
completed857%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14